Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
20,559,947
-
Share change
-
+3,202,186
-
Total reported value
-
$48,027,998
-
Price per share
-
$2.38
-
Number of holders
-
29
-
Value change
-
+$7,603,244
-
Number of buys
-
18
-
Number of sells
-
5
Institutional Holders of SOLENO THERAPEUTICS INC - COM NEW (SLNO) as of Q1 2020
As of 31 Mar 2020,
SOLENO THERAPEUTICS INC - COM NEW (SLNO) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,559,947 shares.
The largest 10 holders included
Abingworth LLP, Nantahala Capital Management, LLC, ORACLE INVESTMENT MANAGEMENT INC, Vivo Capital, LLC, VANGUARD GROUP INC, Trellus Management Company, LLC, 683 Capital Management, LLC, Point72 Asset Management, L.P., J. Goldman & Co LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.